Efavirenz 600mg tabs/PAC-30 gb

General Description
Efavirenz film coated tablets 600mg, pack of 30
(gb = generic / bottle pack)

Technical Specifications
Each film coated tablet contains Efavirenz 600mg

Therapeutic class
Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)

Standard shelf life
2 Years

Other available formulations
The product may also be available in other formulations, pack sizes, or in combinations with other ARVs.

Guidelines for use
For more details, please see WHO treatment guidelines www.who.int/hiv/pub/guidelines/en/index.html and WHO Essential Medicines Library www.who.int/emlib/ or your regional/national guidelines.

Details about paediatric dosage schemes can be found at www.who.int/hiv/topics/paediatric/en/index.html and www.who.int/hiv/paediatric/Sum_WHO_ARV_Ped_ARV_dosing.pdf

NEW: WHO generic tool for assessing paediatric ARV dosing
http://www.who.int/hiv/paediatric/generictool/en/

Indications
Management of HIV infection in adults and children over 3 years of age in combination with at least two other antiretroviral drugs. By mouth (oral) PO.

Storage
Do not store above 30ºC (86ºF), do not freeze.
Store in tightly closed original container
Keep out of reach and sight of children

Dispensing instructions
Dispense in original container. Do not repack
Advise patient to take the medicine on empty stomach and at bedtime, especially in the first 2-4 weeks to reduce CNS effects.
Note: The dose of Efavirenz oral solution in mg of Efavirenz is not the same as for Efavirenz capsules and tablets.

Regulatory Status
For latest updates check the list of ‘Prequalified Medicines’ on the WHO website ‘Prequalification Programme’. apps.who.int/prequal/

For latest updates check the list of ‘USFDA approved and tentatively approved’ items on the USFDA website. www.fda.gov/default.htm, www.accessdata.fda.gov/Scripts/cder/DrugsatFDA/